A Review of Current Guidelines for Depression Treatment
The DOI matches its Crossref record.
Abstract
Article Abstract A variety of American and European guidelines are available for clinicians treating major depressive disorder and depressive subtypes. Major Western guidelines published since 2000 make similar recommendations for all stages of treatment for depression, including a reliance on measurement-based care. First-line treatment is usually a serotonin reuptake inhibitor, psychotherapy, or a combination of pharmacotherapy and psychotherapy. Next-step treatment recommendations are switching or augmentation, depending on patient response to the initial treatment. Maintenance therapy continues the approach that led to remission. The American Psychiatric Association will release a new treatment guideline to offer information on developments made since the last guidelines were published in 2000. Despite progress made during the last decade, no major breakthroughs in the treatment of depression have occurred, and genetic testing developments allowing for personalized care remain the goal of research. This CME activity is expired. For more CME activities, visit cme.psychiatrist.com. Find more articles on this and other psychiatry and CNS topics: The Journal of Clinical Psychiatry The Primary Care Companion for CNS Disorders
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, the dynamic coupling between frontoparietal activation (which increases with task-directed attention) and default mode deactivation is perturbed in MDD 111,117 .”
From Major depressive disorder (2016) · cites this paper as [117]
In the citing paper
“The dominant approach in contemporary medical science views depression through the lens of a biological model, focusing on physiological factors such as neurochemical imbalances, genetic predispositions, and brain-structure anomalies; common interventions include medication (6, 7), positive-thinking activities (8), and social support (6, 8, 9).”
From Anti-stigmatizing: a collaborative autoethnography on recovery from depression (2024) · cites this paper as [8]
Citations
Cites
Still being checked.
Cited by
Items 101–136 of 136
Exploring the potential of drug repurposing for treating depression
Verma, C., Jain, K., Saini, A., Mani, I., & Singh, V. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2024.03.037 · Cited by 3
Fabrissin, J. H., Garay, C. J., Keegan, E. G., Sarudiansky, M., & Korman, G. P. (2014) · SAGE Open · doi:10.1177/2158244014535412 · Cited by 3
Colon, I. E. P., Kroin, J., Kaushal, S. A., Khan, S. A., & Villalba, C. L. A. (2022) · Cureus · doi:10.7759/cureus.31987 · Cited by 4
Use of antidepressant medication and suicidal ideation—the Northern Finland Birth Cohort 1966
Rissanen, I. L., Jääskeläinen, E., Isohanni, M. K., Koponen, H., Joukamaa, M. I., Alaräisänen, A., & Miettunen, J. (2014) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2443 · Cited by 5
Anti-stigmatizing: a collaborative autoethnography on recovery from depression
Zhu, D., & Lyu, K. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1360967 · Cited by 2
“…views depression through the lens of a biological model, focusing on physiological factors such as neurochemical imbalances, genetic predispositions, and brain-structure anomalies; common interventions include medication (6, 7), positive-thinking activities (8), and social support (6, 8, 9).”
Selecting Antidepressants Based on Medical History and Stress Mechanism
Min, H., Alemi, F., & Wojtusiak, J. (2023) · Cureus · doi:10.7759/cureus.37117 · Cited by 3
Han, K., Park, S., Won, E., Sung, S.-H., Lee, H., Koo, J.-W., Lee, K., Lee, H.-Y., Paik, J., Jeon, H. J., et al. (2013) · 신경정신의학 · doi:10.4306/jknpa.2013.52.5.386 · Cited by 2
Dalhuisen, I., Biemans, T., Vos, C. F., ter Hark, S. E., van Oostrom, I., Spijker, J., Wijnen, B. F. M., van Exel, E. R., van Mierlo, H. C., de Waardt, D., et al. (2025) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-025-02012-0 · Cited by 3
Cognitive Benefits and Challenges of Gaming
Zadey, S., Kelleher, B., & Vasa, J. (2025) · Springer eBooks · doi:10.1007/978-3-032-00325-6_11 · Cited by 1
Connectomic Determinants of Subcallosal Cingulate Deep Brain Stimulation for Depression
Song, H. N., Choi, K. S., Kopell, B. H., Figee, M., de Bruin, J., Cha, J., Riva‐Posse, P., Boutet, A., Elias, G. J. B., Germann, J., et al. (2026) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20250449 · Cited by 3
Evidence Based Practice : Aerobic Exercise and Major Depressive Disorder
Qan`ir, Y. (2015) · Middle East Journal of Nursing · doi:10.5742/mejn.2015.92649 · Cited by 3
Kharaman, N., Taghvaei, D., & Jahangiri, M. (2022) · Iranian Evolutionary Educational Psychology Journal · doi:10.52547/ieepj.4.4.138 · Cited by 2
Nazree, N. E., Mohamed, Z., Reynolds, G. P., Zain, S. M., Masiran, R., Sidi, H., Chong, L. A., Yee, A. H. A., Adlan, A. S. A., & Zainal, N. Z. (2015) · Asia-Pacific Psychiatry · doi:10.1111/appy.12210 · Cited by 2
Schneider, C., & Wissink, T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35868-2.00005-0 · Cited by 2
Dialectical behavior therapy stepped care for hospitals
Babeva, K. N., Fitzpatrick, O. M., & Asarnow, J. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816384-9.00013-0 · Cited by 2
Schneider, C., & Lovett, E. A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1793-8.00004-2 · Cited by 1
Fagiolini, A. M., Amodeo, G., & Maina, G. (2017) · doi:10.1093/med/9780198746638.003.0010 · Cited by 1
Lubiński, W., Grabek-Kujawa, H., Dańczura, E., Kucharska–Mazur, J., Samochowiec, J., & Mularczyk, M. (2022) · Klinika Oczna · doi:10.5114/ko.2022.114992 · Cited by 1
Antidepressant-Antianxiety Agents
Baldessarini, R. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3710-9_4 · Cited by 1
Hanson, C. S., Logeman, C., Dew, M. A., & Palmer, S. C. (2022) · Wiley eBooks · doi:10.1002/9781119105954.ch73 · Cited by 1
Ketamine reverses stress-induced hypersensitivity to sunk costsPreprint
Cuttoli, R. D.-D., & Sweis, B. M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.12.593597 · Cited by 1
Arteaga, A., Tong, X., Zhao, K., Carlisle, N. B., Oathes, D. J., Fonzo, G. A., Keller, C. J., & Zhang, Y. (2024) · medRxiv · doi:10.1101/2024.09.22.24314146 · Cited by 1
Cha, H.-A. (2016) · Psychiatry Depression & Anxiety · doi:10.24966/pda-0150/100005
Crnic, A. (2014) · uO Research (University of Ottawa) · doi:10.20381/ruor-6628 · Cited by 1
Qi, S.-A., & Chen, J. (2020) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc44109.2020.9175580
Poor sleep in medicated patients with remitted depressive disorder: A naturalistic study
Lee, I., Lu, T., Chen, P. S., Chen, K., & Yang, Y. K. (2020) · Taiwanese Journal of Psychiatry · doi:10.4103/tpsy.tpsy_10_20
Probióticos na modulação intestinal como adjuvante no tratamento de sinais e sintomas de depressão
Oliveira, E. M. B., de Moura, M. A., de Assunção, L. D. S., da Luz, A. C. R., Atan, A. K., Matos, R. L., da Silva, J. D. A. L. P., Moreira, T. H. G., Cardoso, J. A., de Assunção, F. B. R., et al. (2021) · Research Society and Development · doi:10.33448/rsd-v10i8.16634 · Cited by 2
Assessment of Vitamin D Levels and Depression Among Adults in the United States
Owens, T. J.-L. (2015) · ScholarWorks (Walden University)
THE ADVANTAGES OF NON-INVASIVE BRAIN STIMULATION FOR PATIENTS WITH MAJOR DEPRESSIVE DISORDER (MDD)
Nabila, R. (2022) · Journal of Psychiatry Psychology and Behavioral Research · doi:10.21776/ub.jppbr.2022.003.01.11
Mesripour, A., Khayambashi, M. F., & Sadeghi, M. (2025) · Journal of Research in Pharmacy · doi:10.12991/jrespharm.1797830
Walter, K. H., Otis, N. P., Ray, T. N., Glassman, L. H., Beltran, J. L., Kobayashi Elliott, K. T., & Michalewicz-Kragh, B. (2024) · Figshare · doi:10.6084/m9.figshare.26569516
Müller, S., Keller, A., Wagner, T., & Hoffmann, L. (2021) · Specialty journal of Pharmacognosy Phytochemistry and Biotechnology · doi:10.51847/zgnkximaii
Medication adherence following pharmacogenomic testing in patients with major depressive disorder
Tredici, A. L. D., Johnson, H. L., DeHart, W. B., Gutin, A., Taber, K. J., Morin, P. E., Becker, L., Chawla, D., & Nierenberg, A. A. (2026) · Psychiatry Research · doi:10.1016/j.psychres.2026.117339
Curley, L. E., Lin, J. C., & Chen, T. F. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-26472-6.00217-5
Metadata
- Authors
- Gelenberg, A. J.
- Affiliations
- Pennsylvania State University (US)
- Corresponding author
- Gelenberg, Alan J.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2010-07-15
- Volume
- 71
- Issue
- 07
- Pages
- e15
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2048724816
- Semantic Scholar
- 6cee0e165857b7cd98891dc1aa9fafab5dea6104
- Cited by
- 137
- References
- 0
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 11 · 2023: 12 · 2022: 11 · 2021: 11 · 2020: 14 · 2019: 5 · 2018: 5 · 2017: 10 · 2016: 6 · 2015: 8 · 2014: 14 · 2013: 5 · 2012: 7
- FWCI
- 4.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- major depressive disorder, measurement-based care, first-line therapy, serotonin reuptake inhibitors, psychotherapy, treatment switching, augmentation therapy, maintenance therapy, personalized medicine, genetic testing
- MeSH terms
- Algorithms, Antidepressive Agents, Combined Modality Therapy, Major Depressive Disorder, Depressive Disorder, Humans, Psychotherapy, Research, Practice Guidelines as Topic, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.